Avid Bioservices Inc Revenue Growth Rates (CDMO), Current and Historic Growth - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• Revenue Y/Y
• Op. Income Y/Y
• Cop. Income Y/Y
• Net Income Y/Y
• Eps Cop. Y/Y
• Eps Net Y/Y
• Free Cash Flow Y/Y
• Cash Flow Y/Y
• Capex Y/Y
• Sales Y/Y Annual
Avid Bioservices Inc   (NASDAQ: CDMO)
 

CDMO's Revenue Growth by Quarter and Year

Avid Bioservices Inc 's Revenue results by quarter and year



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

CDMO Revenue (in millions $) FY 2025 FY 2024 FY 2023 FY 2022
4th Quarter April -
3rd Quarter January -
2nd Quarter October 33.48
1st Quarter July 40.17
FY 73.65

CDMOs Annual Revenue
Avid Bioservices Inc 's Revenue in the fiscal year 2024 $ 139.32 millions
Avid Bioservices Inc 's Revenue in the fiscal year 2023 $ 148.48 millions
Avid Bioservices Inc 's Revenue in the fiscal year 2022 $ 119.60 millions
Avid Bioservices Inc 's Revenue in the fiscal year 2021 $ 95.87 millions
Avid Bioservices Inc 's Revenue in the fiscal year 2020 $ 59.70 millions




CDMO Revenue second quarter 2025 Y/Y Growth Comment
Avid Bioservices Inc reported Revenue improvement of 32.13% year on year in the second quarter 2025, to $ 33.48 millions, this is lower than Avid Bioservices Inc 's recent average Revenue improvement of 33.27%.

Looking into second quarter 2025 results within Major Pharmaceutical Preparations industry 72 other companies have achieved higher Revenue growth. While Avid Bioservices Inc ' s Revenue rise of 32.13% ranks overall at the positon no. 580 in the second quarter 2025.


CDMO Revenue ( Y/Y Growth %) 2025
 2024 2023 2022
4th Quarter April - 11.51 % 24.91 % 13.11 %
3rd Quarter January - -12.2 % 20.66 % 44.48 %
2nd Quarter October 32.13 % -27.1 % 33.13 % 23.98 %
1st Quarter July 8.27 % 1.12 % 19.32 % 21.11 %
FY   - -6.17 % 24.15 % -

Financial Statements
Avid Bioservices Inc 's second quarter 2025 Revenue $ 33.48 millions CDMO's Income Statement
Avid Bioservices Inc 's second quarter 2024 Revenue $ 25.34 millions Quarterly CDMO's Income Statement


CDMO Revenue (Quarter on Quarter Growth %)

 2025
 2024 2023 2022
4th Quarter April - 30.32 % 2.6 % -0.89 %
3rd Quarter January - 31.73 % 9.38 % 20.68 %
2nd Quarter October -16.65 % -31.7 % -5.26 % -15.09 %
1st Quarter July -7.66 % -4.9 % 17.48 % 11.37 %
FY (Year on Year)   - -6.17 % 24.15 % -


Back to CDMO Growth rate Comparisons >> Back to CDMO Growth rate Comparisons >>


Revenue second quarter 2025 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #73
Healthcare Sector #167
Overall #580

Revenue Y/Y Growth Statistics
High Average Low
382.74 % 33.27 % -61.22 %
(Jul 31 2017)   (Jul 31 2018)
Revenue second quarter 2025 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #73
Healthcare Sector #167
Overall #580
Revenue Y/Y Growth Statistics
High Average Low
382.74 % 33.27 % -61.22 %
(Jul 31 2017)   (Jul 31 2018)

Revenue by Quarter for the Fiscal Years 2022, 2023, 2024, 2025

Avid Bioservices Inc 's Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
316.65 % 15.96 % -70.14 %
(Oct 31 2016)  


CDMO's II. Quarter Q/Q Revenue Comment
In the II. Quarter 2025 Avid Bioservices Inc disclosed fall in Revenue from the first quarter by -16.65% to $ 33.48 millions, from $ 40.17 millions achived in the previous reporting period.

But that's not important problem, as Avid Bioservices Inc 's Revenue generally seem to plunge in this quarter.

Within Major Pharmaceutical Preparations industry 202 other companies have achieved higher Revenue quarter on quarter growth. While Avid Bioservices Inc 's Revenue growth quarter on quarter, overall rank is 3824.


Revenue Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #203
Healthcare Sector #562
Overall #3824
Revenue Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #203
Healthcare Sector #562
Overall #3824
Revenue Q/Q Growth Statistics
High Average Low
316.65 % 15.96 % -70.14 %
(Oct 31 2016)  


CDMO's II. Quarter Q/Q Revenue Comment
In the II. Quarter 2025 Avid Bioservices Inc disclosed fall in Revenue from the first quarter by -16.65% to $ 33.48 millions, from $ 40.17 millions achived in the previous reporting period.

But that's not important problem, as Avid Bioservices Inc 's Revenue generally seem to plunge in this quarter.

Within Major Pharmaceutical Preparations industry 202 other companies have achieved higher Revenue quarter on quarter growth. While Avid Bioservices Inc 's Revenue growth quarter on quarter, overall rank is 3824.


Avid Bioservices Inc 's 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(Oct 31 2024)		 12 Months Ending
(Jul 31 2024)		 12 Months Ending
(Apr 30 2024)		 12 Months Ending
(Jan 31 2024)		 12 Months Ending
(Oct 31 2023)
Cumulative Revenue 12 Months Ending $ 150.54 $ 142.39 $ 139.32 $ 134.83 $ 139.47
Y / Y Revenue Growth (TTM) 7.94 % -4.36 % -6.17 % -4.17 % 3.94 %
Year on Year Revenue Growth Overall Ranking # 1464 # 692 # 436 # 986 # 627
Seqeuential Revenue Change (TTM) 5.72 % 2.21 % 3.33 % -3.32 % -6.33 %
Seq. Revenue Growth (TTM) Overall Ranking # 2613 # 1898 # 1215 # 2111 # 1551


Cumulative Revenue growth Comment
Although Avid Bioservices Inc 's Annual Revenue growth year on year were below company's average 23.93% , Revenue announced in the Oct 31 2024 period, show improvement in Revenue trend, to cumulative trailing twelve month growth of 7.94% year on year, from -4.36% in Jul 31 2024.

In the Healthcare sector 267 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 692 to 1464.

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 142
Healthcare Sector # 268
Overall # 1464

Revenue TTM Y/Y Growth Statistics
High Average Low
94.71 %
 23.93 %
-50.53 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 142
Sector # 402
S&P 500 # 2613
Cumulative Revenue growth Comment
Although Avid Bioservices Inc 's Annual Revenue growth year on year were below company's average 23.93% , Revenue announced in the Oct 31 2024 period, show improvement in Revenue trend, to cumulative trailing twelve month growth of 7.94% year on year, from -4.36% in Jul 31 2024.

In the Healthcare sector 267 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 692 to 1464.


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 142
Healthcare Sector # 268
Overall # 1464

Revenue TTM Y/Y Growth Statistics
High Average Low
94.71 %
23.93 %
-50.53 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 142
Sector # 402
S&P 500 # 2613




Other Revenue Growth
Major Pharmaceutical Preparations Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
CDMO's Revenue Growth Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth




Companies with similar Revenue fall for the quarter ending Oct 31 2024 within Healthcare SectorY/Y Change %Revenue for the quarter ending Oct 31 2024
Nutriband Inc 50.94%$ 50.943 millions
Lakeland Industries Inc 44.46%$ 44.457 millions
Avid Bioservices Inc 32.16%$ 32.157 millions
Champions Oncology Inc 16.56%$ 16.556 millions


About Avid Bioservices Inc Revenue Growth Rates (CDMO), Current and Historic Growth - CSIMarket Analysis

How we calculate this

This page is based on issuer-reported fundamentals and CSIMarket’s U.S. equities database (20+ years). Growth is computed using year-over-year (Y/Y), sequential, and trailing-twelve-month (TTM) methods.

What’s included here

Company: Avid Bioservices Inc (CIK 704562).

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings → XBRL parse → normalization CSIMarket.com Database → growth calculations.
  • Accession: 0001683168-24-008620
  • Figures are derived from filed reports and may be restated; numbers are subject to revision.

Sources: Avid Bioservices Inc ’s SEC filings (XBRL/Inline XBRL) and CSIMarket.com’s normalization & QA processes.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.